ALBT2 - COFEPRIS Registration 1564R2020 SSA
Access comprehensive regulatory information for ALBT2 (ALBT2) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1564R2020 SSA and manufactured by PRODUCTOS ROCHE, S.A. DEC.V.. The device was registered on November 26, 2020.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
LA PRUEBA ALBT2, SE UTILIZA PARA LADETERMINACIÓN CUANTITATIVA DE LAALBÚMINA EN ORINA, SUERO, PLASMA Y LCR(COCIENTE ALBÚMINA EN LCR/SUERO),HUMANOS EN LOS SISTEMAS ROCHE/HITACHICOBASC. AGENTEDEDIAGNÓSTICOPARAUSOIN VITRO. PARA USO EXCLUSIVO ENLABORATORIOS CLÍNICOS O DE GABINETES.
THE ALBT2 TEST IS USED FOR THE QUANTITATIVE DETERMINATION OF ALBUMIN IN URINE, SERUM, PLASMA AND CSF (ALBUMIN RATIO IN CSF / SERUM), HUMANS IN THE ROCHE / HITACHICOBASC SYSTEMS. DIAGNOSTIC AGENTFORUSE in VITRO. FOR USE ONLY IN CLINICAL LABORATORIES OR CABINETS.